AM-Pharma is a Dutch clinical stage biopharmaceutical company developing a treatment for acute kidney injury (AKI) that could be lifesaving. The Company does not produce face masks or other medical equipment.
PUBLICATIONS
- Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury 24 October 2018
- Effects of a human recombinant alkaline phosphatase during impaired mitochondrial function in human renal proximal tubule epithelial cells 22 December 2016
- Effects of a human recombinant alkaline phosphatase on renal hemodynamics, oxygenation and inflammation in two models of acute kidney injury 17 October 2016
- Study protocol for a multicentre randomised controlled trial: Safety, Tolerability, efficacy and quality of life Of a human recombinant alkaline Phosphatase in patients with sepsis-associated Acute Kidney Injury (STOP-AKI) 27 September 2016
- Human recombinant alkaline phosphatase inhibits ex vivo platelet activation in humans 22 September 2016
- Pharmacokinetic Modeling and Dose Selection in a Randomized, Double-Blind, Placebo-Controlled Trial of a Human Recombinant Alkaline Phosphatase in Healthy Volunteers 4 May 2016
- Biodistribution and translational pharmacokinetic modeling of a human recombinant alkaline phosphatase 29 August 2015
- Alkaline phosphatase protects against renal inflammation through dephosphorylation of lipopolysaccharide and adenosine triphosphate 29 July 2015
- Improvement of the skeletal and dental hypophosphatasia phenotype in Alpl−/− mice by administration of soluble (non-targeted) chimeric alkaline phosphatase 26 November 2014
- Catalytic Signature of a Heat-Stable, Chimeric Human Alkaline Phosphatase with Therapeutic Potential 24 February 2014
- Alkaline phosphatase as a treatment for sepsis-associated acute kidney injury 6 November 2012
- Alkaline phosphatase in sepsis-induced AKI 14 February 2012
- Alkaline phosphatase for treatment of sepsisinduced acute kidney injury: a prospective randomized double-blind placebo-controlled trial 23 January 2012
- The Protective Role of Intestinal Alkaline Phosphatase in Necrotizing Enterocolitis 21 May 2010
- Exogenous Alkaline Phosphatase for the Treatment of Patients with Moderate to Severe Ulcerative Colitis 2 November 2009
- Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients 1 February 2009
- Role of alkaline phosphatase in colitis in man and rats 13 October 2008
